Twist Bioscience (TWST) said Thursday it launched animal-origin-free and transfection-grade plasmid DNA preparation products for nucleic acid therapeutics research.
The new products are designed to meet specific quality needs for preclinical studies, including low or endotoxin-free requirements for work involving sensitive cells, according to Twist.